2018 Global Next Generation Cancer Diagnostics Industry Report - History, Present and Future

November 2018 | 143 pages | ID: 2992C25D493PEN
Prof Research

Abstracts

The global market size of Next Generation Cancer Diagnostics is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:

• North America
• South America
• Asia & Pacific
• Europe
• MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Next Generation Cancer Diagnostics as well as some small players. The compnaies include:

Cepheid, Koninklijke Philips N.V, F. Hoffmann-La Roche Ltd, Qiagen, Novartis AG, Abbott, Thermo Fisher Scientific, Opko Health, Myriad Genetics, Agilent Technologies et al.

The information for each competitor includes:

• Company Profile
• Main Business Information
• SWOT Analysis
• Sales, Revenue, Price and Gross Margin
• Market Share

We also can offer customized report to fulfill special requirements of our clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Next Generation Cancer Diagnostics Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Next Generation Cancer Diagnostics by Region
8.2 Import of Next Generation Cancer Diagnostics by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT NEXT GENERATION CANCER DIAGNOSTICS MARKET IN NORTH AMERICA (2013-2018)

9.1 Next Generation Cancer Diagnostics Supply
9.2 Next Generation Cancer Diagnostics Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT NEXT GENERATION CANCER DIAGNOSTICS MARKET IN SOUTH AMERICA (2013-2018)

10.1 Next Generation Cancer Diagnostics Supply
10.2 Next Generation Cancer Diagnostics Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT NEXT GENERATION CANCER DIAGNOSTICS MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Next Generation Cancer Diagnostics Supply
11.2 Next Generation Cancer Diagnostics Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT NEXT GENERATION CANCER DIAGNOSTICS MARKET IN EUROPE (2013-2018)

12.1 Next Generation Cancer Diagnostics Supply
12.2 Next Generation Cancer Diagnostics Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT NEXT GENERATION CANCER DIAGNOSTICS MARKET IN MEA (2013-2018)

13.1 Next Generation Cancer Diagnostics Supply
13.2 Next Generation Cancer Diagnostics Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET (2013-2018)

14.1 Next Generation Cancer Diagnostics Supply
14.2 Next Generation Cancer Diagnostics Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET FORECAST (2019-2023)

15.1 Next Generation Cancer Diagnostics Supply Forecast
15.2 Next Generation Cancer Diagnostics Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(CEPHEID, KONINKLIJKE PHILIPS N.V, F. HOFFMANN-LA ROCHE LTD, QIAGEN, NOVARTIS AG, ABBOTT, THERMO FISHER SCIENTIFIC, OPKO HEALTH, MYRIAD GENETICS, AGILENT TECHNOLOGIES ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Next Generation Cancer Diagnostics Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Next Generation Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Next Generation Cancer Diagnostics Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Next Generation Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Next Generation Cancer Diagnostics Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Next Generation Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Next Generation Cancer Diagnostics Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Next Generation Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Next Generation Cancer Diagnostics Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Next Generation Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Next Generation Cancer Diagnostics Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Next Generation Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Next Generation Cancer Diagnostics Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Next Generation Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Next Generation Cancer Diagnostics Report
Table Primary Sources of Next Generation Cancer Diagnostics Report
Table Secondary Sources of Next Generation Cancer Diagnostics Report
Table Major Assumptions of Next Generation Cancer Diagnostics Report
Figure Next Generation Cancer Diagnostics Picture
Table Next Generation Cancer Diagnostics Classification
Table Next Generation Cancer Diagnostics Applications List
Table Drivers of Next Generation Cancer Diagnostics Market
Table Restraints of Next Generation Cancer Diagnostics Market
Table Opportunities of Next Generation Cancer Diagnostics Market
Table Threats of Next Generation Cancer Diagnostics Market
Table Key Raw Material of Next Generation Cancer Diagnostics and Its Suppliers
Table Key Technologies of Next Generation Cancer Diagnostics
Table Cost Structure of Next Generation Cancer Diagnostics
Table Market Channel of Next Generation Cancer Diagnostics
Table Next Generation Cancer Diagnostics Application and Key End Users List
Table Latest News of Next Generation Cancer Diagnostics Industry
Table Recently Merger and Acquisition List of Next Generation Cancer Diagnostics Industry
Table Recently Planned/Future Project List of Next Generation Cancer Diagnostics Industry
Table Policy Dynamics Update of Next Generation Cancer Diagnostics Industry
Table 2013-2023 Export of Next Generation Cancer Diagnostics by Region
Table 2013-2023 Import of Next Generation Cancer Diagnostics by Region
Table 2013-2023 Balance of Trade of Next Generation Cancer Diagnostics
Figure 2013 2018 and 2023 Global Trade Map of Next Generation Cancer Diagnostics
Table 2013-2018 North America Supply of Next Generation Cancer Diagnostics
Figure 2013-2018 North America Next Generation Cancer Diagnostics Supply and GAGR
Table 2013-2018 North America Next Generation Cancer Diagnostics Downstream Demand List
Figure 2013-2018 North America Next Generation Cancer Diagnostics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Next Generation Cancer Diagnostics Demand by Type
Figure 2013-2018 North America Next Generation Cancer Diagnostics Price
Table 2013-2018 Key Countries Supply of Next Generation Cancer Diagnostics in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Next Generation Cancer Diagnostics in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Next Generation Cancer Diagnostics
Figure 2013-2018 South America Next Generation Cancer Diagnostics Supply and GAGR
Table 2013-2018 South America Next Generation Cancer Diagnostics Downstream Demand List
Figure 2013-2018 South America Next Generation Cancer Diagnostics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Next Generation Cancer Diagnostics Demand by Type
Figure 2013-2018 South America Next Generation Cancer Diagnostics Price
Table 2013-2018 Key Countries Supply of Next Generation Cancer Diagnostics in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Next Generation Cancer Diagnostics in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Next Generation Cancer Diagnostics
Figure 2013-2018 Asia & Pacific Next Generation Cancer Diagnostics Supply and GAGR
Table 2013-2018 Asia & Pacific Next Generation Cancer Diagnostics Downstream Demand List
Figure 2013-2018 Asia & Pacific Next Generation Cancer Diagnostics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Next Generation Cancer Diagnostics Demand by Type
Figure 2013-2018 Asia & Pacific Next Generation Cancer Diagnostics Price
Table 2013-2018 Key Countries Supply of Next Generation Cancer Diagnostics in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Next Generation Cancer Diagnostics in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Next Generation Cancer Diagnostics
Figure 2013-2018 Europe Next Generation Cancer Diagnostics Supply and GAGR
Table 2013-2018 Europe Next Generation Cancer Diagnostics Downstream Demand List
Figure 2013-2018 Europe Next Generation Cancer Diagnostics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Next Generation Cancer Diagnostics Demand by Type
Figure 2013-2018 Europe Next Generation Cancer Diagnostics Price
Table 2013-2018 Key Countries Supply of Next Generation Cancer Diagnostics in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Next Generation Cancer Diagnostics in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Next Generation Cancer Diagnostics
Figure 2013-2018 MEA Next Generation Cancer Diagnostics Supply and GAGR
Table 2013-2018 MEA Next Generation Cancer Diagnostics Downstream Demand List
Figure 2013-2018 MEA Next Generation Cancer Diagnostics Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Next Generation Cancer Diagnostics Demand by Type
Figure 2013-2018 MEA Next Generation Cancer Diagnostics Price
Table 2013-2018 Key Countries Supply of Next Generation Cancer Diagnostics in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Next Generation Cancer Diagnostics in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Next Generation Cancer Diagnostics by Region
Figure 2013-2018 Global Supply and CAGR of Next Generation Cancer Diagnostics by Region
Table 2013-2018 Global Next Generation Cancer Diagnostics Downstream Demand List by Region
Figure 2013-2018 Global Next Generation Cancer Diagnostics Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Next Generation Cancer Diagnostics Type-wise Demand by Region
Figure 2013-2018 Global Next Generation Cancer Diagnostics Price
Table Main Business and Next Generation Cancer Diagnostics Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Next Generation Cancer Diagnostics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Next Generation Cancer Diagnostics Sales Revenue and Growth Rate
Figure 2013-2018 Company A Next Generation Cancer Diagnostics Market Share
Table Main Business and Next Generation Cancer Diagnostics Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Next Generation Cancer Diagnostics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Next Generation Cancer Diagnostics Sales Revenue and Growth Rate
Figure 2013-2018 Company B Next Generation Cancer Diagnostics Market Share
Table Main Business and Next Generation Cancer Diagnostics Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Next Generation Cancer Diagnostics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Next Generation Cancer Diagnostics Sales Revenue and Growth Rate
Figure 2013-2018 Company C Next Generation Cancer Diagnostics Market Share
Table Main Business and Next Generation Cancer Diagnostics Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Next Generation Cancer Diagnostics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Next Generation Cancer Diagnostics Sales Revenue and Growth Rate
Figure 2013-2018 Company D Next Generation Cancer Diagnostics Market Share
Table Main Business and Next Generation Cancer Diagnostics Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Next Generation Cancer Diagnostics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Next Generation Cancer Diagnostics Sales Revenue and Growth Rate
Figure 2013-2018 Company E Next Generation Cancer Diagnostics Market Share
Table Main Business and Next Generation Cancer Diagnostics Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Next Generation Cancer Diagnostics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Next Generation Cancer Diagnostics Sales Revenue and Growth Rate
Figure 2013-2018 Company F Next Generation Cancer Diagnostics Market Share
Table Main Business and Next Generation Cancer Diagnostics Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Next Generation Cancer Diagnostics Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Next Generation Cancer Diagnostics Sales Revenue and Growth Rate
Figure 2013-2018 Company G Next Generation Cancer Diagnostics Market Share